Literature DB >> 32205320

Use of Checkpoint Inhibitors in a Kidney Transplant Recipient with Metastatic Cancer.

Song Ching Ong1, Roslyn B Mannon2.   

Abstract

Entities:  

Keywords:  Neoplasms; Second Primary; cancer; kidney transplantation; rejection; renal transplantation

Mesh：

Substances：

Year:  2020        PMID： 32205320      PMCID： PMC7409757          DOI： 10.2215/CJN.15941219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Checkpoint blockade after kidney transplantation.

Authors:  Mathieu Lesouhaitier; Caroline Dudreuilh; Mathilde Tamain; Nada Kanaan; Elodie Bailly; Delphine Legoupil; Clement Deltombe; Peggy Perrin; Guillaume Manson; Cécile Vigneau; Roch Houot
Journal:  Eur J Cancer       Date:  2018-04-26       Impact factor: 9.162

Review 2.  Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?

Authors:  Pauline De Bruyn; Dirk Van Gestel; Piet Ost; Vibeke Kruse; Lieve Brochez; Hans Van Vlierberghe; Arnaud Devresse; Véronique Del Marmol; Alain Le Moine; Sandrine Aspeslagh
Journal:  Curr Opin Oncol       Date:  2019-03       Impact factor: 3.645

3.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

Review 4.  Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?

Authors:  Mark A Perazella; Anushree C Shirali
Journal:  Kidney Int       Date:  2019-08-23       Impact factor: 10.612

Review 5.  Kidney Complications of Immune Checkpoint Inhibitors: A Review.

Authors:  Roman Shingarev; Ilya G Glezerman
Journal:  Am J Kidney Dis       Date:  2019-07-11       Impact factor: 8.860

Review 6.  Immune-related adverse events with immune checkpoint blockade: a comprehensive review.

Authors:  J M Michot; C Bigenwald; S Champiat; M Collins; F Carbonnel; S Postel-Vinay; A Berdelou; A Varga; R Bahleda; A Hollebecque; C Massard; A Fuerea; V Ribrag; A Gazzah; J P Armand; N Amellal; E Angevin; N Noel; C Boutros; C Mateus; C Robert; J C Soria; A Marabelle; O Lambotte
Journal:  Eur J Cancer       Date:  2016-01-05       Impact factor: 9.162

7.  The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Donald F Chute; Leyre Zubiri; Yaa Oppong; Ian Strohbehn; Frank B Cortazar; David E Leaf; Meghan J Mooradian; Alexandra-Chloé Villani; Ryan J Sullivan; Kerry Reynolds; Meghan E Sise
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-31       Impact factor: 8.237

8.  Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.

Authors:  Noha Abdel-Wahab; Houssein Safa; Ala Abudayyeh; Daniel H Johnson; Van Anh Trinh; Chrystia M Zobniw; Heather Lin; Michael K Wong; Maen Abdelrahim; A Osama Gaber; Maria E Suarez-Almazor; Adi Diab
Journal:  J Immunother Cancer       Date:  2019-04-16       Impact factor: 13.751

9.  Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients.

Authors:  Sandhya Manohar; Charat Thongprayoon; Wisit Cheungpasitporn; Svetomir N Markovic; Sandra M Herrmann
Journal:  Kidney Int Rep       Date:  2019-12-07

10.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.